Literature DB >> 15720550

Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC).

Hyeryun Choe1, Michael J Moore, Christopher M Owens, Paulette L Wright, Natalya Vasilieva, Wenhui Li, Agam P Singh, Rushdi Shakri, Chetan E Chitnis, Michael Farzan.   

Abstract

Plasmodium vivax is one of four Plasmodium species that cause human malaria. P. vivax and a related simian malaria parasite, Plasmodium knowlesi, invade erythrocytes by binding the Duffy antigen/receptor for chemokines (DARC) through their respective Duffy binding proteins. Here we show that tyrosines 30 and 41 of DARC are modified by addition of sulphate groups, and that the sulphated tyrosine 41 is essential for association of the Duffy binding proteins of P. vivax (PvDBP) and P. knowlesi (PkDaBP) with DARC-expressing cells. These sulphated tyrosines also participate in the association of DARC with each of its four known chemokine ligands. Alteration of tyrosine 41 to phenylalanine interferes with MCP-1, RANTES and MGSA association with DARC, but not with that of IL8. In contrast, alteration of tyrosine 30 to phenylalanine interferes with the association of IL8 with DARC. A soluble sulphated amino-terminal domain of DARC, but not one modified to phenylalanine at residue 41, can be used to block the association of PvDBP and PkDaBP with red blood cells, with an IC50 of approximately 5 nM. These data are consistent with a role for tyrosine sulphation in the association of many or most chemokines with their receptors, and identify a key molecular determinant of erythrocyte invasion by P. vivax.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15720550     DOI: 10.1111/j.1365-2958.2004.04478.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  63 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

2.  Cross-Species Immune Recognition Between Plasmodium vivax Duffy Binding Protein Antibodies and the Plasmodium falciparum Surface Antigen VAR2CSA.

Authors:  Sédami Gnidehou; Catherine J Mitran; Eliana Arango; Shanna Banman; Angie Mena; Evelyn Medawar; Barbara A S Lima; Justin Doritchamou; Jahanara Rajwani; Albert Jin; Kenneth Gavina; Francis Ntumngia; Patrick Duffy; David Narum; Nicaise Tuikue Ndam; Morten A Nielsen; Ali Salanti; Flora S Kano; Luzia H Carvalho; John H Adams; Amanda Maestre; Michael F Good; Stephanie K Yanow
Journal:  J Infect Dis       Date:  2019-01-01       Impact factor: 5.226

3.  The crystal structure of P. knowlesi DBPalpha DBL domain and its implications for immune evasion.

Authors:  Amy M McHenry; John H Adams
Journal:  Trends Biochem Sci       Date:  2006-07-27       Impact factor: 13.807

4.  Evaluation and extension of the two-site, two-step model for binding and activation of the chemokine receptor CCR1.

Authors:  Julie Sanchez; Zil E Huma; J Robert Lane; Xuyu Liu; Jessica L Bridgford; Richard J Payne; Meritxell Canals; Martin J Stone
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

Review 5.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

6.  Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies.

Authors:  Patchanee Chootong; Francis B Ntumngia; Kelley M VanBuskirk; Jia Xainli; Jennifer L Cole-Tobian; Christopher O Campbell; Tresa S Fraser; Christopher L King; John H Adams
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

7.  Efficient expression of tyrosine-sulfated proteins in E. coli using an expanded genetic code.

Authors:  Chang C Liu; Susan E Cellitti; Bernhard H Geierstanger; Peter G Schultz
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

8.  Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans.

Authors:  Karthigayan Gunalan; Eugenia Lo; Jessica B Hostetler; Delenasaw Yewhalaw; Jianbing Mu; Daniel E Neafsey; Guiyun Yan; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-17       Impact factor: 11.205

Review 9.  Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.

Authors:  Francis B Ntumngia; Christopher L King; John H Adams
Journal:  Int J Parasitol       Date:  2012-10-12       Impact factor: 3.981

10.  Analysis of structure and function of the giant protein Pf332 in Plasmodium falciparum.

Authors:  Anthony N Hodder; Alexander G Maier; Melanie Rug; Monica Brown; Mirja Hommel; Ivan Pantic; Marina Puig-de-Morales-Marinkovic; Brian Smith; Tony Triglia; James Beeson; Alan F Cowman
Journal:  Mol Microbiol       Date:  2008-11-05       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.